Details of Disease

General Information of Disease (ID: DIS0QBRC)

Disease Name Obstructive hypertrophic cardiomyopathy
Disease Class BC43: Cardiomyopathy
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DIS0QBRC: Obstructive hypertrophic cardiomyopathy
ICD Code
ICD-11
ICD-11: BC43.12
ICD-10
ICD-10: I42.1
Expand ICD-11
'BC43.12
Expand ICD-10
'I42.1

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Mavacamten DMK9BP2 Approved NA [1]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
MYK-224 DMEERGA Phase 2 NA [2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 214998.
2 ClinicalTrials.gov (NCT05556343) A Phase 2a, Open-label, Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction (MERCUTIO). U.S.National Institutes of Health.